This is a Validated Antibody Database (VAD) review about human MUC1, based on 111 published articles (read how Labome selects the articles), using MUC1 antibody in all methods. It is aimed to help Labome visitors find the most suited MUC1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
MUC1 synonym: ADMCKD; ADMCKD1; CA 15-3; CD227; EMA; H23AG; KL-6; MAM6; MCD; MCKD; MCKD1; MUC-1; MUC-1/SEC; MUC-1/X; MUC1/ZD; PEM; PEMT; PUM

Knockout validation
Invitrogen
hamsters monoclonal (MH1 (CT2))
  • immunohistochemistry knockout validation; mouse; loading ...; fig 2d
  • western blot knockout validation; mouse; loading ...; fig 2b
  • immunohistochemistry; human; fig 1c
In order to test if MUC1 contributes to epithelial tubular cell plasticity and kidney fibrosis, Invitrogen MUC1 antibody (ThermoFisher, MA5-11202) was used in immunohistochemistry knockout validation on mouse samples (fig 2d), in western blot knockout validation on mouse samples (fig 2b) and in immunohistochemistry on human samples (fig 1c). Biochim Biophys Acta Mol Basis Dis (2017) ncbi
Invitrogen
hamsters monoclonal (MH1 (CT2))
  • immunohistochemistry - paraffin section; mouse; 1:1000; loading ...; fig 4c
Invitrogen MUC1 antibody (ThermoFisher, MA5-11202) was used in immunohistochemistry - paraffin section on mouse samples at 1:1000 (fig 4c). Nat Commun (2020) ncbi
hamsters monoclonal (MH1 (CT2))
  • immunohistochemistry; mouse; 1:100; loading ...; fig 1h
Invitrogen MUC1 antibody (ThermoFisher Scientific, HM-1630-PO) was used in immunohistochemistry on mouse samples at 1:100 (fig 1h). Cell Mol Gastroenterol Hepatol (2019) ncbi
hamsters monoclonal (MH1 (CT2))
  • western blot; human; loading ...; fig 1c
Invitrogen MUC1 antibody (Thermo FisherScientific, MA511202) was used in western blot on human samples (fig 1c). J Cell Physiol (2019) ncbi
hamsters monoclonal (MH1 (CT2))
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 5e
Invitrogen MUC1 antibody (NeoMarkers, HM-1630-P1) was used in immunohistochemistry - paraffin section on mouse samples (fig 5e). Cell (2019) ncbi
hamsters monoclonal (MH1 (CT2))
  • immunohistochemistry knockout validation; mouse; loading ...; fig 2d
  • western blot knockout validation; mouse; loading ...; fig 2b
  • immunohistochemistry; human; fig 1c
In order to test if MUC1 contributes to epithelial tubular cell plasticity and kidney fibrosis, Invitrogen MUC1 antibody (ThermoFisher, MA5-11202) was used in immunohistochemistry knockout validation on mouse samples (fig 2d), in western blot knockout validation on mouse samples (fig 2b) and in immunohistochemistry on human samples (fig 1c). Biochim Biophys Acta Mol Basis Dis (2017) ncbi
hamsters monoclonal (MH1 (CT2))
  • western blot; human; loading ...; fig 2
In order to determine effects of the MUC1-C subunit inhibitor (GO-203) on human colorectal cancer cells, Invitrogen MUC1 antibody (Thermo Scientific, Ab5) was used in western blot on human samples (fig 2). Mol Cancer (2017) ncbi
mouse monoclonal (S.854.6)
  • immunocytochemistry; human; loading ...
In order to test if tumor irradiation augments the immune response to MUC1 tumor antigen, Invitrogen MUC1 antibody (Thermo Fisher, S.854.6) was used in immunocytochemistry on human samples . J Immunother Cancer (2017) ncbi
mouse monoclonal (E29)
  • immunohistochemistry - paraffin section; human; 1:50; loading ...; tbl 3
In order to characterize cases of oncocytic papillary renal cell carcinoma, Invitrogen MUC1 antibody (Thermo, E29) was used in immunohistochemistry - paraffin section on human samples at 1:50 (tbl 3). Pathol Res Pract (2017) ncbi
hamsters monoclonal (MH1 (CT2))
  • immunohistochemistry - paraffin section; human; 1:50; fig 4
In order to study a case report and literature review of recurrent intracranial neurenteric cyst with malignant transformation, Invitrogen MUC1 antibody (Thermo Fisher, MA5-11202) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 4). Oncol Lett (2016) ncbi
hamsters monoclonal (MH1 (CT2))
  • chromatin immunoprecipitation; human; loading ...; fig 3b
  • immunohistochemistry; human; 1:200; fig 6b
  • western blot; human; loading ...; fig 1b
In order to determine that MUC1 stimulates epidermal growth factor receptor expression and function in endometrial cancer, Invitrogen MUC1 antibody (ProSci, MH1) was used in chromatin immunoprecipitation on human samples (fig 3b), in immunohistochemistry on human samples at 1:200 (fig 6b) and in western blot on human samples (fig 1b). Oncotarget (2016) ncbi
hamsters monoclonal (MH1 (CT2))
  • immunohistochemistry - paraffin section; mouse; 1:200; fig 7
In order to study the contribution of hematopoietically expressed homeobox protein in ductal secretion and pancreatitis, Invitrogen MUC1 antibody (NeoMarkers, 1630X1210A) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 7). Cell Mol Gastroenterol Hepatol (2015) ncbi
mouse monoclonal (GP1.4)
  • western blot; human; loading ...; fig 1f
In order to investigate the role of MUC1 on macrophage differentiation or phagocytic activity, Invitrogen MUC1 antibody (Pierce, GP1.4) was used in western blot on human samples (fig 1f). Am J Respir Cell Mol Biol (2016) ncbi
hamsters monoclonal (MH1 (CT2))
  • immunohistochemistry - paraffin section; human; 1:200
In order to determine if miRNA that target Muc1 are protective against pancreatic cancer, Invitrogen MUC1 antibody (Neomarkers Labvision, HM-1630P1) was used in immunohistochemistry - paraffin section on human samples at 1:200. Biochim Biophys Acta (2015) ncbi
hamsters monoclonal (MH1 (CT2))
  • immunohistochemistry - paraffin section; mouse; 1:200
In order to investigate the role of transcription factors SOX4 and SOX9 during the development of bile ducts, Invitrogen MUC1 antibody (Neomarkers, HM-1630-P) was used in immunohistochemistry - paraffin section on mouse samples at 1:200. Dev Biol (2015) ncbi
mouse monoclonal (GP1.4)
  • immunohistochemistry - paraffin section; human; fig 5
  • flow cytometry; human; fig 1
  • western blot; human; fig 1
In order to study the shift of Smad3 signaling from the tumor-suppressive pSmad3C/p21(WAF1) pathway to the oncogenic pSmad3L/c-Myc pathway occurs by Mucin1 activating JNK in human hepatocellular carcinoma cells, Invitrogen MUC1 antibody (Neomarker, GP1.4) was used in immunohistochemistry - paraffin section on human samples (fig 5), in flow cytometry on human samples (fig 1) and in western blot on human samples (fig 1). Oncotarget (2015) ncbi
hamsters monoclonal (MH1 (CT2))
  • immunocytochemistry; human; fig 3
  • western blot; human; fig 3
In order to study the shift of Smad3 signaling from the tumor-suppressive pSmad3C/p21(WAF1) pathway to the oncogenic pSmad3L/c-Myc pathway occurs by Mucin1 activating JNK in human hepatocellular carcinoma cells, Invitrogen MUC1 antibody (Neomarker, Ab-5) was used in immunocytochemistry on human samples (fig 3) and in western blot on human samples (fig 3). Oncotarget (2015) ncbi
mouse monoclonal (GP1.4)
  • immunohistochemistry; human; 1:400
In order to describe a tumor from a patient with oncocytic cystadenoma, Invitrogen MUC1 antibody (Thermo Scientific, GP1.4) was used in immunohistochemistry on human samples at 1:400. Medicine (Baltimore) (2014) ncbi
mouse monoclonal (E29)
  • immunohistochemistry - paraffin section; human; 1:50
In order to describe two cases of trichilemmal carcinoma, Invitrogen MUC1 antibody (Thermo Fisher Scientific, E29) was used in immunohistochemistry - paraffin section on human samples at 1:50. Rom J Morphol Embryol (2014) ncbi
mouse monoclonal (GP1.4)
  • immunohistochemistry - paraffin section; human
In order to compare meningiomas and mesotheliomas immunohistochemically, Invitrogen MUC1 antibody (Thermo Scientific, GP1.4) was used in immunohistochemistry - paraffin section on human samples . Biomed Res Int (2014) ncbi
mouse monoclonal (E29)
  • immunohistochemistry - paraffin section; human; 1:200; tbl 2
In order to report the clinicopathological features of 9 breast malignant fibrous histiocytoma patients, Invitrogen MUC1 antibody (Lab Vision, E29) was used in immunohistochemistry - paraffin section on human samples at 1:200 (tbl 2). Sci Rep (2013) ncbi
mouse monoclonal (E29)
  • immunohistochemistry; human; tbl 1
In order to report the case of primary acinic cell carcinoma of the breast in a 38-year-old woman, Invitrogen MUC1 antibody (Zymed, E29) was used in immunohistochemistry on human samples (tbl 1). Int J Surg Pathol (2014) ncbi
hamsters monoclonal (MH1 (CT2))
In order to examine the anti-tumor potential of BCR-ABL disruption and secondary leukemia-specific pathway inhibitors, Invitrogen MUC1 antibody (Thermo Scientific, MUC-1 Ab-5/HM-1630) was used . Mol Pharm (2013) ncbi
hamsters monoclonal (MH1 (CT2))
  • immunohistochemistry - paraffin section; mouse; 1:300
In order to study the roles of GATA4 and GATA6 in mouse pancreas organogenesis, Invitrogen MUC1 antibody (Thermo, HM-1630,) was used in immunohistochemistry - paraffin section on mouse samples at 1:300. J Clin Invest (2012) ncbi
hamsters monoclonal (MH1 (CT2))
  • western blot; African green monkey; 0.04 ug/ml
  • immunocytochemistry; human; 0.67 ug/ml; fig 7
  • western blot; human; 0.04 ug/ml
  • immunohistochemistry; rhesus macaque; 0.4 ug/ml; fig 2
In order to determine if MUC1-N is expressed inside the nucleus, Invitrogen MUC1 antibody (Thermo Fisher, HM-1630-P0) was used in western blot on African green monkey samples at 0.04 ug/ml, in immunocytochemistry on human samples at 0.67 ug/ml (fig 7), in western blot on human samples at 0.04 ug/ml and in immunohistochemistry on rhesus macaque samples at 0.4 ug/ml (fig 2). PLoS ONE (2012) ncbi
hamsters monoclonal (MH1 (CT2))
  • immunohistochemistry - frozen section; mouse; 1:500; fig 1
In order to investigate the origins of new beta-cells, Invitrogen MUC1 antibody (NeoMarkers, HM-1630-P1) was used in immunohistochemistry - frozen section on mouse samples at 1:500 (fig 1). BMC Dev Biol (2010) ncbi
Abcam
domestic rabbit monoclonal (EP1024Y)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 1b
  • immunohistochemistry; human; 1:50; loading ...; fig 3a
  • western blot; human; 1:1000; loading ...; fig 4b
Abcam MUC1 antibody (Abcam, ab45167) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1b), in immunohistochemistry on human samples at 1:50 (fig 3a) and in western blot on human samples at 1:1000 (fig 4b). Bone Joint Res (2022) ncbi
domestic rabbit monoclonal (EPR1023)
  • immunohistochemistry; mouse; 1:250; loading ...; fig 1a
Abcam MUC1 antibody (Abcam, ab109185) was used in immunohistochemistry on mouse samples at 1:250 (fig 1a). JCI Insight (2020) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; 1:100; loading ...; fig 1a
Abcam MUC1 antibody (Abcam, ab15481) was used in immunohistochemistry on mouse samples at 1:100 (fig 1a). JCI Insight (2020) ncbi
(MH1)
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; fig 6f
Abcam MUC1 antibody (Abcam, ab80952) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 6f). elife (2020) ncbi
(MH1)
  • immunohistochemistry - frozen section; human; 1:500; loading ...; fig 5c
Abcam MUC1 antibody (Abcam, ab80952) was used in immunohistochemistry - frozen section on human samples at 1:500 (fig 5c). Nat Commun (2019) ncbi
domestic rabbit monoclonal (EP1024Y)
  • western blot; human; loading ...; fig 3a
Abcam MUC1 antibody (Abcam, ab45167) was used in western blot on human samples (fig 3a). J Mol Med (Berl) (2019) ncbi
domestic rabbit monoclonal (EPR1023)
  • flow cytometry; human; loading ...; fig s6
In order to investigate origin of tumor-infiltrating T regulatory cells in breast cancer samples, Abcam MUC1 antibody (Abcam, ab109185) was used in flow cytometry on human samples (fig s6). Cell Res (2017) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 5
Abcam MUC1 antibody (Abcam, ab15481) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 5). Am J Cancer Res (2016) ncbi
domestic rabbit monoclonal (EP1024Y)
  • western blot; human; 1:1000; loading ...; fig 4a
Abcam MUC1 antibody (Abcam, ab45167) was used in western blot on human samples at 1:1000 (fig 4a). Int J Cancer (2017) ncbi
(MH1)
  • western blot; mouse; fig 1d
  • immunoprecipitation; human; fig 2d
  • western blot; human; fig 1a,1b
Abcam MUC1 antibody (Abcam, ab80952) was used in western blot on mouse samples (fig 1d), in immunoprecipitation on human samples (fig 2d) and in western blot on human samples (fig 1a,1b). Oncotarget (2016) ncbi
(MH1)
  • chromatin immunoprecipitation; human; loading ...; fig 3b
  • immunohistochemistry; human; 1:200; fig 6b
  • western blot; human; loading ...; fig 1b
In order to determine that MUC1 stimulates epidermal growth factor receptor expression and function in endometrial cancer, Abcam MUC1 antibody (ProSci, MH1) was used in chromatin immunoprecipitation on human samples (fig 3b), in immunohistochemistry on human samples at 1:200 (fig 6b) and in western blot on human samples (fig 1b). Oncotarget (2016) ncbi
domestic rabbit monoclonal (EP1024Y)
  • immunohistochemistry; rat; 1:200; fig 1b
In order to study intra-abdominal hypertension-induced changes in gastrointestinal permeability, Abcam MUC1 antibody (Abcam, ab45167) was used in immunohistochemistry on rat samples at 1:200 (fig 1b). Sci Rep (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; fig s3
Abcam MUC1 antibody (Abcam, ab15481) was used in immunohistochemistry - paraffin section on mouse samples (fig s3). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (C595)
  • other; human; 1:100; fig 6
Abcam MUC1 antibody (Abcam, ab28081) was used in other on human samples at 1:100 (fig 6). Cancer Cell Int (2015) ncbi
mouse monoclonal (SM3)
  • western blot; human; loading ...; fig 1g
Abcam MUC1 antibody (abcam, ab22711) was used in western blot on human samples (fig 1g). Oncotarget (2015) ncbi
domestic rabbit monoclonal (EP1024Y)
  • immunohistochemistry - paraffin section; human; 1:200
Abcam MUC1 antibody (Abcam, ab45167) was used in immunohistochemistry - paraffin section on human samples at 1:200. Exp Mol Pathol (2014) ncbi
domestic rabbit monoclonal (EPR1023)
  • western blot; human
Abcam MUC1 antibody (Epitomics, 2900-1) was used in western blot on human samples . Oncogene (2015) ncbi
Santa Cruz Biotechnology
mouse monoclonal (0.N.272)
  • immunohistochemistry; human; 1:200; loading ...; fig 2g
Santa Cruz Biotechnology MUC1 antibody (Santa Cruz Biotechnology, sc-71615) was used in immunohistochemistry on human samples at 1:200 (fig 2g). Endocrinology (2019) ncbi
mouse monoclonal (BC-2)
  • western blot; human; fig 7
In order to study the favored formation of polarized salivary acinar-like structures by the role of human fibronectin- or placenta basement membrane extract-based gels, Santa Cruz Biotechnology MUC1 antibody (Santa Cruz, SC-52347) was used in western blot on human samples (fig 7). J Tissue Eng Regen Med (2017) ncbi
mouse monoclonal (VU4H5)
  • western blot; human
Santa Cruz Biotechnology MUC1 antibody (Santa Cruz, sc-7313) was used in western blot on human samples . Biomaterials (2015) ncbi
mouse monoclonal (E29)
Santa Cruz Biotechnology MUC1 antibody (Santa Cruz Biotechnology, sc-53377) was used . Am J Pathol (2015) ncbi
mouse monoclonal (VU4H5)
  • immunohistochemistry; human; 1:200
Santa Cruz Biotechnology MUC1 antibody (Santa Cruz Biotechnology, VU4H5) was used in immunohistochemistry on human samples at 1:200. Virchows Arch (2015) ncbi
mouse monoclonal (VU4H5)
  • immunohistochemistry - paraffin section; human; 1:1000
  • ELISA; human
Santa Cruz Biotechnology MUC1 antibody (santa, sc7313) was used in immunohistochemistry - paraffin section on human samples at 1:1000 and in ELISA on human samples . Int J Oncol (2015) ncbi
Novus Biologicals
domestic rabbit monoclonal (SM3)
  • immunohistochemistry - frozen section; mouse; 1:100; loading ...; fig 5c
Novus Biologicals MUC1 antibody (Novus, NBP2-62561) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 5c). Front Immunol (2022) ncbi
domestic rabbit polyclonal
  • immunoprecipitation; human; loading ...; fig 2c
Novus Biologicals MUC1 antibody (Novus, NBP1-60046) was used in immunoprecipitation on human samples (fig 2c). J Cell Physiol (2019) ncbi
BioLegend
mouse monoclonal (16A)
  • flow cytometry; human; 1:100
BioLegend MUC1 antibody (BioLegend, 355604) was used in flow cytometry on human samples at 1:100. Front Cell Dev Biol (2015) ncbi
mouse monoclonal (16A)
  • flow cytometry; human; fig s4
BioLegend MUC1 antibody (BioLegend, 355603) was used in flow cytometry on human samples (fig s4). J Mol Cell Biol (2015) ncbi
Dako
mouse monoclonal (E29)
  • immunohistochemistry; human; loading ...; fig 1e
Dako MUC1 antibody (DAKO Corp, M0613) was used in immunohistochemistry on human samples (fig 1e). Cancers (Basel) (2020) ncbi
mouse monoclonal (E29)
  • immunohistochemistry; human; 1:250
Dako MUC1 antibody (DAKO, E29) was used in immunohistochemistry on human samples at 1:250. Sci Rep (2020) ncbi
mouse monoclonal (E29)
  • other; human; loading ...; fig 4c
Dako MUC1 antibody (Dako, M0613) was used in other on human samples (fig 4c). Cancer Cell (2018) ncbi
mouse monoclonal (E29)
  • immunohistochemistry - paraffin section; human
In order to discover that pediatric glioneuronal tumor with neuropil-like islands samples appear different at the molecular level, Dako MUC1 antibody (DAKO, E29) was used in immunohistochemistry - paraffin section on human samples . Am J Cancer Res (2016) ncbi
mouse monoclonal (E29)
  • immunohistochemistry - paraffin section; human; loading ...; fig 3b
Dako MUC1 antibody (Dako, E29) was used in immunohistochemistry - paraffin section on human samples (fig 3b). J Cutan Pathol (2017) ncbi
mouse monoclonal (E29)
  • immunohistochemistry; human; 1:200; loading ...
In order to present the case of a patient with gingival and both palatine tonsils localization of a grade-two angiosarcoma, Dako MUC1 antibody (Dako, E29) was used in immunohistochemistry on human samples at 1:200. Rare Tumors (2016) ncbi
mouse monoclonal (E29)
  • immunohistochemistry - paraffin section; human; loading ...; fig 2
Dako MUC1 antibody (DAKO, E29) was used in immunohistochemistry - paraffin section on human samples (fig 2). Int J STD AIDS (2017) ncbi
mouse monoclonal (E29)
  • immunohistochemistry - paraffin section; human; 1:1000; loading ...; tbl 2
In order to characterize 21 cases of biphasic squamoid alveolar renal cell carcinoma, Dako MUC1 antibody (DakoCytomation, E29) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (tbl 2). Am J Surg Pathol (2016) ncbi
mouse monoclonal (E29)
  • immunohistochemistry - paraffin section; human; 1:50; loading ...
In order to characterize and present the first case of fibroblastic reticular cell tumor of the breast, Dako MUC1 antibody (Dako, E29) was used in immunohistochemistry - paraffin section on human samples at 1:50. Exp Ther Med (2016) ncbi
mouse monoclonal (E29)
  • immunohistochemistry - paraffin section; human; 1:400; fig 3
Dako MUC1 antibody (Dako, E29) was used in immunohistochemistry - paraffin section on human samples at 1:400 (fig 3). Histopathology (2016) ncbi
mouse monoclonal (E29)
  • immunohistochemistry - paraffin section; human; 1:100; fig 5
Dako MUC1 antibody (Dako, M0613) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 5). PLoS ONE (2015) ncbi
mouse monoclonal (E29)
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; fig 3
Dako MUC1 antibody (Dako, E29) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 3). Ann Diagn Pathol (2015) ncbi
mouse monoclonal (E29)
  • immunohistochemistry; human; tbl 1
Dako MUC1 antibody (DAKO, E29) was used in immunohistochemistry on human samples (tbl 1). Int J Clin Exp Pathol (2015) ncbi
mouse monoclonal (E29)
  • immunohistochemistry - paraffin section; human; 1:250
In order to describe a patient diagnosed with a noninvasive intestinal-type mucinous ovarian borderline tumor presenting with pleural metastases, Dako MUC1 antibody (DAKO, E29) was used in immunohistochemistry - paraffin section on human samples at 1:250. Int J Gynecol Pathol (2015) ncbi
mouse monoclonal (E29)
  • immunohistochemistry - paraffin section; black ferret; 1:50; tbl 3
In order to use of ferrets to characterize immunohistochemical and histochemical levels of chordoma, Dako MUC1 antibody (Dakopatts, E29) was used in immunohistochemistry - paraffin section on black ferret samples at 1:50 (tbl 3). J Vet Med Sci (2015) ncbi
mouse monoclonal (E29)
  • immunohistochemistry; human
In order to characterize human tracheal basal cells, Dako MUC1 antibody (Dako Cytomation, M0613) was used in immunohistochemistry on human samples . Respir Res (2014) ncbi
mouse monoclonal (E29)
  • immunohistochemistry - paraffin section; human; 1:250
Dako MUC1 antibody (DAKO, E29) was used in immunohistochemistry - paraffin section on human samples at 1:250. Diagn Pathol (2014) ncbi
mouse monoclonal (E29)
  • immunohistochemistry - paraffin section; human; 1:600
Dako MUC1 antibody (DAKO, E29) was used in immunohistochemistry - paraffin section on human samples at 1:600. Cancer Med (2015) ncbi
mouse monoclonal (E29)
  • immunohistochemistry; human; 1:100; fig 4
Dako MUC1 antibody (DakoCytomation, M0613) was used in immunohistochemistry on human samples at 1:100 (fig 4). PLoS ONE (2014) ncbi
mouse monoclonal (E29)
  • immunohistochemistry; human; 1:50
In order to identify tissue origin of the granular cell tumor using immunohistochemistry, Dako MUC1 antibody (Dako, E29) was used in immunohistochemistry on human samples at 1:50. Arch Dermatol Res (2015) ncbi
mouse monoclonal (E29)
  • immunohistochemistry - paraffin section; human; 1:200
Dako MUC1 antibody (DAKO, E29) was used in immunohistochemistry - paraffin section on human samples at 1:200. Endocr Pathol (2014) ncbi
mouse monoclonal (E29)
  • immunohistochemistry - paraffin section; human; 1:1000
Dako MUC1 antibody (DAKO, E29) was used in immunohistochemistry - paraffin section on human samples at 1:1000. Hum Pathol (2014) ncbi
mouse monoclonal (E29)
  • immunohistochemistry; human; 1:100
Dako MUC1 antibody (DAKO, E29) was used in immunohistochemistry on human samples at 1:100. Diagn Pathol (2014) ncbi
mouse monoclonal (E29)
  • immunohistochemistry - paraffin section; human
Dako MUC1 antibody (Dako, E29) was used in immunohistochemistry - paraffin section on human samples . Virchows Arch (2014) ncbi
mouse monoclonal (E29)
  • immunohistochemistry; human
Dako MUC1 antibody (DakoCytomation, E29) was used in immunohistochemistry on human samples . Pathol Int (2014) ncbi
mouse monoclonal (E29)
  • immunohistochemistry; human; 1:250
In order to discuss Ewing sarcoma, Dako MUC1 antibody (Dako, M061301) was used in immunohistochemistry on human samples at 1:250. Histopathology (2014) ncbi
mouse monoclonal (E29)
  • immunohistochemistry - paraffin section; domestic sheep; 1:100
Dako MUC1 antibody (Dako Cytomation, E29) was used in immunohistochemistry - paraffin section on domestic sheep samples at 1:100. Virchows Arch (2014) ncbi
mouse monoclonal (E29)
  • immunohistochemistry - paraffin section; bovine
Dako MUC1 antibody (Dako, M0613) was used in immunohistochemistry - paraffin section on bovine samples . Int J Mol Sci (2014) ncbi
mouse monoclonal (E29)
  • blocking or activating experiments; human
Dako MUC1 antibody (Dako, M0613) was used in blocking or activating experiments on human samples . Int J Oncol (2014) ncbi
mouse monoclonal (E29)
  • immunohistochemistry; human; 1:50
In order to describe a pineal anaplastic giant cell ependymoma, Dako MUC1 antibody (DAKO, E29) was used in immunohistochemistry on human samples at 1:50. Histol Histopathol (2014) ncbi
mouse monoclonal (E29)
  • immunohistochemistry - paraffin section; rat
Dako MUC1 antibody (DAKO, M0613) was used in immunohistochemistry - paraffin section on rat samples . Mol Cancer Res (2014) ncbi
mouse monoclonal (E29)
  • immunohistochemistry; human; fig 1
In order to identify and characterize BRAF mutation from patients with metanephric adenomas, Dako MUC1 antibody (Dako, E29) was used in immunohistochemistry on human samples (fig 1). Cancer Genet (2013) ncbi
mouse monoclonal (E29)
  • immunohistochemistry; human; 1:50
In order to describe histological features of a tumor from a patient with pleuropulmonary blastoma, Dako MUC1 antibody (Dako, E29) was used in immunohistochemistry on human samples at 1:50. Fetal Pediatr Pathol (2014) ncbi
mouse monoclonal (E29)
  • immunohistochemistry; human; 1:100
In order to characterize a rare case of gliosarcoma, Dako MUC1 antibody (dako, E29) was used in immunohistochemistry on human samples at 1:100. Clin Neuropathol (2013) ncbi
mouse monoclonal (E29)
  • immunocytochemistry; human
In order to measure the expression of epithelial-to-mesenchymal transition-associated proteins in renal cell carcinoma and compared expression levels with clinical outcome, Dako MUC1 antibody (Dako, M0613) was used in immunocytochemistry on human samples . PLoS ONE (2012) ncbi
Cell Signaling Technology
mouse monoclonal (VU4H5)
  • immunohistochemistry - paraffin section; human; loading ...; fig 2f
Cell Signaling Technology MUC1 antibody (Cell signaling, 4538S) was used in immunohistochemistry - paraffin section on human samples (fig 2f). Cell Res (2019) ncbi
mouse monoclonal (VU4H5)
  • immunocytochemistry; human; fig 1
  • western blot; human; fig 1
In order to analyze cancer cell plasticity autonomous stimulation by human NKG2D lymphocyte receptor coexpressed with its ligands on cancer cells, Cell Signaling Technology MUC1 antibody (Cell Signaling Technology, VU4H5) was used in immunocytochemistry on human samples (fig 1) and in western blot on human samples (fig 1). PLoS ONE (2014) ncbi
mouse monoclonal (VU4H5)
  • western blot; human
Cell Signaling Technology MUC1 antibody (cell signaling, #4538) was used in western blot on human samples . Biometals (2014) ncbi
Fitzgerald Industries
mouse monoclonal (M002204)
  • ELISA; human; 1:3000; fig 1g
Fitzgerald Industries MUC1 antibody (Fitzgerald, 10-C03E) was used in ELISA on human samples at 1:3000 (fig 1g). Arch Pharm Res (2018) ncbi
Abfrontier
mouse monoclonal (1B7)
  • immunocytochemistry; human; loading ...; fig 2c
Abfrontier MUC1 antibody (AbFrontier, YF-MA14321) was used in immunocytochemistry on human samples (fig 2c). Biosens Bioelectron (2018) ncbi
BD Biosciences
mouse monoclonal (HMPV)
  • flow cytometry; human; loading ...; fig 5d
BD Biosciences MUC1 antibody (BD Biosciences, 559774) was used in flow cytometry on human samples (fig 5d). Nat Commun (2022) ncbi
mouse monoclonal (HMPV)
  • western blot; human; loading ...; fig s1b
BD Biosciences MUC1 antibody (BD, 555925) was used in western blot on human samples (fig s1b). Cell (2019) ncbi
mouse monoclonal (HMPV)
  • immunohistochemistry; human; loading ...; fig 4a
BD Biosciences MUC1 antibody (BD Biosciences, 555925) was used in immunohistochemistry on human samples (fig 4a). ACS Biomater Sci Eng (2018) ncbi
mouse monoclonal (HMPV)
  • flow cytometry; human; tbl 3
In order to document and describe lymphocyte predominant cells from lymph nodes involved in nodular lymphocyte predominant Hodgkin lymphoma, BD Biosciences MUC1 antibody (BD Pharmingen, HMPV) was used in flow cytometry on human samples (tbl 3). Am J Pathol (2017) ncbi
mouse monoclonal (HMPV)
  • immunohistochemistry - paraffin section; human; loading ...; fig 4b
In order to study the effect of PIK3CA in breast cancer., BD Biosciences MUC1 antibody (BD Bioscience, 550486) was used in immunohistochemistry - paraffin section on human samples (fig 4b). PLoS ONE (2016) ncbi
mouse monoclonal (HMPV)
  • immunocytochemistry; human; loading ...; fig S1B
BD Biosciences MUC1 antibody (BD Biosciences, HMPV) was used in immunocytochemistry on human samples (fig S1B). Oncotarget (2016) ncbi
mouse monoclonal (HMPV)
  • flow cytometry; human; fig st1
In order to find cell-surface markers specific to human neutrophils, BD Biosciences MUC1 antibody (BD, 559774) was used in flow cytometry on human samples (fig st1). Exp Cell Res (2016) ncbi
mouse monoclonal (HMPV)
  • immunohistochemistry - paraffin section; human; 1:400; fig 1
In order to analyze a model for ductal pancreatic cancer and drug screening, BD Biosciences MUC1 antibody (BD Biosciences, 555925) was used in immunohistochemistry - paraffin section on human samples at 1:400 (fig 1). Nat Med (2015) ncbi
mouse monoclonal (HMPV)
  • flow cytometry; human; fig 2
In order to analyze the contribution of genetic alterations and cell type of origin in breast cancer phenotypes, BD Biosciences MUC1 antibody (BD Bioscience, MUC1-559774) was used in flow cytometry on human samples (fig 2). Oncotarget (2015) ncbi
mouse monoclonal (HMPV)
  • flow cytometry; human; fig 1
  • immunocytochemistry; human; fig s10
In order to study and identify critical cell lineage-dependent transduction bias to model breast cancer properly, BD Biosciences MUC1 antibody (BD Biosciences, HMPV) was used in flow cytometry on human samples (fig 1) and in immunocytochemistry on human samples (fig s10). Nat Commun (2015) ncbi
mouse monoclonal (HMPV)
  • flow cytometry; human; 1:50
BD Biosciences MUC1 antibody (BD Bioscience, 559774) was used in flow cytometry on human samples at 1:50. Front Cell Dev Biol (2015) ncbi
mouse monoclonal (HMPV)
  • flow cytometry; human
In order to show that intermediate DNA methylation is a conserved signature of gene regulation and exon usage, BD Biosciences MUC1 antibody (BD Biosciences, 559774) was used in flow cytometry on human samples . Nat Commun (2015) ncbi
mouse monoclonal (HMPV)
  • flow cytometry; human
In order to discover regulatory networks from epigenomes of surface ectoderm-derived cell types, BD Biosciences MUC1 antibody (BD Biosciences, 559774) was used in flow cytometry on human samples . Nat Commun (2014) ncbi
Leica Biosystems
mouse monoclonal (MA552)
  • immunohistochemistry; human; 1:100; loading ...; fig 1a
Leica Biosystems MUC1 antibody (Novocastra, Ma552) was used in immunohistochemistry on human samples at 1:100 (fig 1a). Oncol Lett (2021) ncbi
monoclonal (GP1.4)
  • immunohistochemistry - paraffin section; human; 1:350; loading ...; fig 2d
Leica Biosystems MUC1 antibody (Leica Biosystems, PA0039) was used in immunohistochemistry - paraffin section on human samples at 1:350 (fig 2d). Leuk Res (2018) ncbi
mouse monoclonal (MA552)
  • immunohistochemistry - paraffin section; human; 1:150; fig 5a
Leica Biosystems MUC1 antibody (Novocastra, NCL-MUC01) was used in immunohistochemistry - paraffin section on human samples at 1:150 (fig 5a). Am J Cancer Res (2017) ncbi
mouse monoclonal (MA552)
  • immunohistochemistry; human; tbl 1
In order to describe the molecular typing of hobnail variant of papillary thyroid carcinoma, Leica Biosystems MUC1 antibody (Novocastra, Ma695) was used in immunohistochemistry on human samples (tbl 1). Endocr Relat Cancer (2017) ncbi
  • immunohistochemistry; human; 1:400
In order to characterize and present the features observed in sixteen cases of solid pseudopapillary neoplasm of the pancreas, Leica Biosystems MUC1 antibody (Novocastra, NCL-L-EMA) was used in immunohistochemistry on human samples at 1:400. Kaohsiung J Med Sci (2016) ncbi
monoclonal (GP1.4)
  • immunohistochemistry; human; 1:600; tbl 2
In order to characterize eleven cases of primary glial and neuronal tumors of the ovary or peritoneum, Leica Biosystems MUC1 antibody (Novocastra, GP1.4) was used in immunohistochemistry on human samples at 1:600 (tbl 2). Am J Surg Pathol (2016) ncbi
monoclonal (GP1.4)
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; tbl 1
In order to present a case of cellular spindle cell neoplasm with features of both cellular schwannoma and pseudoglandular schwannoma, Leica Biosystems MUC1 antibody (Leica, GP1.4) was used in immunohistochemistry - paraffin section on human samples at 1:200 (tbl 1). Am J Dermatopathol (2016) ncbi
monoclonal (GP1.4)
  • immunohistochemistry - paraffin section; human
In order to describe an unusual case of a recurrent dural neoplasm, Leica Biosystems MUC1 antibody (Novocastra, GP1.4) was used in immunohistochemistry - paraffin section on human samples . Hum Pathol (2015) ncbi
mouse monoclonal (MA552)
  • immunohistochemistry; human; 1:400
In order to investigate the prognostic significance of a three-protein biomarker panel for prostate cancer, Leica Biosystems MUC1 antibody (Novocastra, NCL-MUC-1) was used in immunohistochemistry on human samples at 1:400. Cancer Med (2014) ncbi
mouse monoclonal (MA552)
  • immunohistochemistry - paraffin section; human; 1:400
Leica Biosystems MUC1 antibody (Novocastra Laboratories, Ma552) was used in immunohistochemistry - paraffin section on human samples at 1:400. Hum Pathol (2014) ncbi
mouse monoclonal (MA552)
  • immunohistochemistry - paraffin section; human; 1:100
Leica Biosystems MUC1 antibody (Leica Microsystems, NCL-MUC-1) was used in immunohistochemistry - paraffin section on human samples at 1:100. Pancreas (2014) ncbi
Articles Reviewed
  1. Ganieva U, Schneiderman S, Bu P, Beaman K, Dambaeva S. IL-22 regulates endometrial regeneration by enhancing tight junctions and orchestrating extracellular matrix. Front Immunol. 2022;13:955576 pubmed publisher
  2. Zou Y, Zhang X, Liang J, Peng L, Qin J, Zhou F, et al. Mucin 1 aggravates synovitis and joint damage of rheumatoid arthritis by regulating inflammation and aggression of fibroblast-like synoviocytes. Bone Joint Res. 2022;11:639-651 pubmed publisher
  3. Ferguson I, Pati xf1 o Escobar B, Tuomivaara S, Lin Y, Nix M, Leung K, et al. The surfaceome of multiple myeloma cells suggests potential immunotherapeutic strategies and protein markers of drug resistance. Nat Commun. 2022;13:4121 pubmed publisher
  4. Kato T, Ujiie H, Hatanaka K, Nange A, Okumura A, Tsubame K, et al. A novel Tn antigen epitope-recognizing antibody for MUC1 predicts clinical outcome in patients with primary lung adenocarcinoma. Oncol Lett. 2021;21:202 pubmed publisher
  5. Perkail S, Andricovich J, Kai Y, Tzatsos A. BAP1 is a haploinsufficient tumor suppressor linking chronic pancreatitis to pancreatic cancer in mice. Nat Commun. 2020;11:3018 pubmed publisher
  6. Zhang H, Qi L, Du Y, Huang L, Braun F, Kogiso M, et al. Patient-Derived Orthotopic Xenograft (PDOX) Mouse Models of Primary and Recurrent Meningioma. Cancers (Basel). 2020;12: pubmed publisher
  7. Li W, Zhang N, Jin C, Long M, Rajabi H, Yasumizu Y, et al. MUC1-C drives stemness in progression of colitis to colorectal cancer. JCI Insight. 2020;5: pubmed publisher
  8. Somerville T, Biffi G, Da ler Plenker J, Hur S, He X, Vance K, et al. Squamous trans-differentiation of pancreatic cancer cells promotes stromal inflammation. elife. 2020;9: pubmed publisher
  9. de Gooyer J, Versleijen Jonkers Y, Hillebrandt Roeffen M, Frielink C, Desar I, de Wilt J, et al. Immunohistochemical selection of biomarkers for tumor-targeted image-guided surgery of myxofibrosarcoma. Sci Rep. 2020;10:2915 pubmed publisher
  10. Subramanian A, Sidhom E, Emani M, Vernon K, Sahakian N, Zhou Y, et al. Single cell census of human kidney organoids shows reproducibility and diminished off-target cells after transplantation. Nat Commun. 2019;10:5462 pubmed publisher
  11. Haider S, Gamperl M, Burkard T, Kunihs V, Kaindl U, Junttila S, et al. Estrogen Signaling Drives Ciliogenesis in Human Endometrial Organoids. Endocrinology. 2019;160:2282-2297 pubmed publisher
  12. Peng J, Sun B, Chen C, Zhou J, Chen Y, Chen H, et al. Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma. Cell Res. 2019;29:725-738 pubmed publisher
  13. Quilichini E, Fabre M, Dirami T, Stedman A, De Vas M, Ozguc O, et al. Pancreatic ductal deletion of Hnf1b disrupts exocrine homeostasis, leads to pancreatitis and facilitates tumorigenesis. Cell Mol Gastroenterol Hepatol. 2019;: pubmed publisher
  14. Shurer C, Kuo J, Roberts L, Gandhi J, Colville M, Enoki T, et al. Physical Principles of Membrane Shape Regulation by the Glycocalyx. Cell. 2019;: pubmed publisher
  15. Zhang H, Ji J, Liu Q, Xu S. MUC1 downregulation promotes TNF-α-induced necroptosis in human bronchial epithelial cells via regulation of the RIPK1/RIPK3 pathway. J Cell Physiol. 2019;: pubmed publisher
  16. Sharon N, Chawla R, Mueller J, Vanderhooft J, Whitehorn L, Rosenthal B, et al. A Peninsular Structure Coordinates Asynchronous Differentiation with Morphogenesis to Generate Pancreatic Islets. Cell. 2019;176:790-804.e13 pubmed publisher
  17. Tang Z, Ding Y, Shen Q, Zhang C, Li J, Nazar M, et al. KIAA1199 promotes invasion and migration in non-small-cell lung cancer (NSCLC) via PI3K-Akt mediated EMT. J Mol Med (Berl). 2019;97:127-140 pubmed publisher
  18. Shurer C, Colville M, Gupta V, Head S, Kai F, Lakins J, et al. Genetically Encoded Toolbox for Glycocalyx Engineering: Tunable Control of Cell Adhesion, Survival, and Cancer Cell Behaviors. ACS Biomater Sci Eng. 2018;4:388-399 pubmed publisher
  19. Ng P, Li J, Jeong K, Shao S, Chen H, Tsang Y, et al. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell. 2018;33:450-462.e10 pubmed publisher
  20. Jin Y, Kim S, Kim H, Ju W, Kim Y, Kim H. Use of protein-based biomarkers of exfoliated cervical cells for primary screening of cervical cancer. Arch Pharm Res. 2018;41:438-449 pubmed publisher
  21. Cull A, Mahendru D, Snetsinger B, Good D, Tyryshkin K, Chesney A, et al. Overexpression of Arginase 1 is linked to DNMT3A and TET2 mutations in lower-grade myelodysplastic syndromes and chronic myelomonocytic leukemia. Leuk Res. 2018;65:5-13 pubmed publisher
  22. Cho H, Hossain M, Lee J, Han J, Lee H, Kim K, et al. Selective isolation and noninvasive analysis of circulating cancer stem cells through Raman imaging. Biosens Bioelectron. 2018;102:372-382 pubmed publisher
  23. Nastase A, Teo J, Heng H, Ng C, Myint S, Rajasegaran V, et al. Genomic and proteomic characterization of ARID1A chromatin remodeller in ampullary tumors. Am J Cancer Res. 2017;7:484-502 pubmed
  24. Gibier J, Hemon B, Fanchon M, Gaudelot K, Pottier N, Ringot B, et al. Dual role of MUC1 mucin in kidney ischemia-reperfusion injury: Nephroprotector in early phase, but pro-fibrotic in late phase. Biochim Biophys Acta Mol Basis Dis. 2017;1863:1336-1349 pubmed publisher
  25. Su S, Liao J, Liu J, Huang D, He C, Chen F, et al. Blocking the recruitment of naive CD4+ T cells reverses immunosuppression in breast cancer. Cell Res. 2017;27:461-482 pubmed publisher
  26. Ahmad R, Alam M, Hasegawa M, Uchida Y, Al Obaid O, Kharbanda S, et al. Targeting MUC1-C inhibits the AKT-S6K1-elF4A pathway regulating TIGAR translation in colorectal cancer. Mol Cancer. 2017;16:33 pubmed publisher
  27. Hillman G, Reich L, Rothstein S, Abernathy L, Fountain M, Hankerd K, et al. Radiotherapy and MVA-MUC1-IL-2 vaccine act synergistically for inducing specific immunity to MUC-1 tumor antigen. J Immunother Cancer. 2017;5:4 pubmed publisher
  28. Morandi L, Righi A, Maletta F, Rucci P, Pagni F, Gallo M, et al. Somatic mutation profiling of hobnail variant of papillary thyroid carcinoma. Endocr Relat Cancer. 2017;24:107-117 pubmed publisher
  29. Giunti L, Buccoliero A, Pantaleo M, Lucchesi M, Provenzano A, Palazzo V, et al. Molecular characterization of paediatric glioneuronal tumours with neuropil-like islands: a genome-wide copy number analysis. Am J Cancer Res. 2016;6:2910-2918 pubmed
  30. Calle A, Nair N, Oo A, Prieto Vila M, Koga M, Khayrani A, et al. A new PDAC mouse model originated from iPSCs-converted pancreatic cancer stem cells (CSCcm). Am J Cancer Res. 2016;6:2799-2815 pubmed
  31. Macarenco R, Cury Martins J. Extra-acral cutaneous sclerosing perineurioma with CD34 fingerprint pattern. J Cutan Pathol. 2017;44:388-392 pubmed publisher
  32. Fromm J, Thomas A, Wood B. Characterization and Purification of Neoplastic Cells of Nodular Lymphocyte Predominant Hodgkin Lymphoma from Lymph Nodes by Flow Cytometry and Flow Cytometric Cell Sorting. Am J Pathol. 2017;187:304-317 pubmed publisher
  33. Tang Z, Li J, Shen Q, Feng J, Liu H, Wang W, et al. Contribution of upregulated dipeptidyl peptidase 9 (DPP9) in promoting tumoregenicity, metastasis and the prediction of poor prognosis in non-small cell lung cancer (NSCLC). Int J Cancer. 2017;140:1620-1632 pubmed publisher
  34. Bhagirath D, Zhao X, Mirza S, West W, Band H, Band V. Mutant PIK3CA Induces EMT in a Cell Type Specific Manner. PLoS ONE. 2016;11:e0167064 pubmed publisher
  35. Han G, Yu W, Chu J, Liu Y, Jiang Y, Li Y, et al. Oncocytic papillary renal cell carcinoma: A clinicopathological and genetic analysis and indolent clinical course in 14 cases. Pathol Res Pract. 2017;213:1-6 pubmed publisher
  36. Chamberland F, Maurina T, Degano Valmary S, Spicarolen T, Chaigneau L. Angiosarcoma: A Case Report of Gingival Disease with Both Palatine Tonsils Localization. Rare Tumors. 2016;8:5907 pubmed
  37. Di Franco S, Turdo A, Benfante A, Colorito M, Gaggianesi M, Apuzzo T, et al. ?Np63 drives metastasis in breast cancer cells via PI3K/CD44v6 axis. Oncotarget. 2016;7:54157-54173 pubmed publisher
  38. Ugras N, Yerci O, Coşkun S, Ocakoglu G, Sarkut P, Dündar H. Retrospective analysis of clinicopathological features of solid pseudopapillary neoplasm of the pancreas. Kaohsiung J Med Sci. 2016;32:356-61 pubmed publisher
  39. Hanson R, Brown R, Steele M, Grandgenett P, Grunkemeyer J, Hollingsworth M. Identification of FRA-1 as a novel player in pancreatic cancer in cooperation with a MUC1: ERK signaling axis. Oncotarget. 2016;7:39996-40011 pubmed publisher
  40. Wang D, Zheng Y, Zeng D, Yang Y, Zhang X, Feng Y, et al. Clinicopathologic characteristics of HIV/AIDS-related plasmablastic lymphoma. Int J STD AIDS. 2017;28:380-388 pubmed publisher
  41. Maria O, Liu Y, El Hakim M, Zeitouni A, Tran S. The role of human fibronectin- or placenta basement membrane extract-based gels in favouring the formation of polarized salivary acinar-like structures. J Tissue Eng Regen Med. 2017;11:2643-2657 pubmed publisher
  42. Yang Y, Fang J, Li D, Wang L, Ji N, Zhang J. Recurrent intracranial neurenteric cyst with malignant transformation: A case report and literature review. Oncol Lett. 2016;11:3395-3402 pubmed
  43. Engel B, Bowser J, Broaddus R, Carson D. MUC1 stimulates EGFR expression and function in endometrial cancer. Oncotarget. 2016;7:32796-809 pubmed publisher
  44. Hes O, Condom Mundo E, Peckova K, Lopez J, Martinek P, Vanecek T, et al. Biphasic Squamoid Alveolar Renal Cell Carcinoma: A Distinctive Subtype of Papillary Renal Cell Carcinoma?. Am J Surg Pathol. 2016;40:664-75 pubmed publisher
  45. Liang L, Olar A, Niu N, Jiang Y, Cheng W, Bian X, et al. Primary Glial and Neuronal Tumors of the Ovary or Peritoneum: A Clinicopathologic Study of 11 Cases. Am J Surg Pathol. 2016;40:847-56 pubmed publisher
  46. Leng Y, Yi M, Fan J, Bai Y, Ge Q, Yao G. Effects of acute intra-abdominal hypertension on multiple intestinal barrier functions in rats. Sci Rep. 2016;6:22814 pubmed publisher
  47. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed publisher
  48. Li H, Shen P, Liang Y, Zhang F. Fibroblastic reticular cell tumor of the breast: A case report and review of the literature. Exp Ther Med. 2016;11:561-564 pubmed
  49. Su R, Strug M, Jeong J, Miele L, Fazleabas A. Aberrant activation of canonical Notch1 signaling in the mouse uterus decreases progesterone receptor by hypermethylation and leads to infertility. Proc Natl Acad Sci U S A. 2016;113:2300-5 pubmed publisher
  50. Yamada Y, Yamamoto H, Kohashi K, Ishii T, Iura K, Maekawa A, et al. Histological spectrum of angiofibroma of soft tissue: histological and genetic analysis of 13 cases. Histopathology. 2016;69:459-69 pubmed publisher
  51. Sundarkrishnan L, Bradish J, Oliai B, Hosler G. Cutaneous Cellular Pseudoglandular Schwannoma: An Unusual Histopathologic Variant. Am J Dermatopathol. 2016;38:315-8 pubmed publisher
  52. Ferreira M, McKenna L, Zhang J, Reichert M, Bakir B, Buza E, et al. Spontaneous Pancreatitis Caused by Tissue-Specific Gene Ablation of Hhex in Mice. Cell Mol Gastroenterol Hepatol. 2015;1:550-569 pubmed publisher
  53. Batchelder C, Martinez M, Tarantal A. Natural Scaffolds for Renal Differentiation of Human Embryonic Stem Cells for Kidney Tissue Engineering. PLoS ONE. 2015;10:e0143849 pubmed publisher
  54. Stempin S, Engel A, Winkler N, Buhrke T, Lampen A. Morphological and molecular characterization of the human breast epithelial cell line M13SV1 and its tumorigenic derivatives M13SV1-R2-2 and M13SV1-R2-N1. Cancer Cell Int. 2015;15:110 pubmed publisher
  55. Huang L, Holtzinger A, Jagan I, BeGora M, Lohse I, Ngai N, et al. Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell- and patient-derived tumor organoids. Nat Med. 2015;21:1364-71 pubmed publisher
  56. Lu W, Qiu L, Yan Z, Lin Z, Cao M, Hu C, et al. Cytotoxic T cell responses are enhanced by antigen design involving the presentation of MUC1 peptide on cholera toxin B subunit. Oncotarget. 2015;6:34537-48 pubmed publisher
  57. Kato K, Uchino R, Lillehoj E, Knox K, Lin Y, Kim K. Membrane-Tethered MUC1 Mucin Counter-Regulates the Phagocytic Activity of Macrophages. Am J Respir Cell Mol Biol. 2016;54:515-23 pubmed publisher
  58. Badr H, Alsadek D, Mathew M, Li C, Djansugurova L, Yarema K, et al. Nutrient-deprived cancer cells preferentially use sialic acid to maintain cell surface glycosylation. Biomaterials. 2015;70:23-36 pubmed publisher
  59. Haley S, O Hara B, Nelson C, Brittingham F, Henriksen K, Stopa E, et al. Human polyomavirus receptor distribution in brain parenchyma contrasts with receptor distribution in kidney and choroid plexus. Am J Pathol. 2015;185:2246-58 pubmed publisher
  60. Tréhoux S, Lahdaoui F, Delpu Y, Renaud F, Leteurtre E, Torrisani J, et al. Micro-RNAs miR-29a and miR-330-5p function as tumor suppressors by targeting the MUC1 mucin in pancreatic cancer cells. Biochim Biophys Acta. 2015;1853:2392-403 pubmed publisher
  61. Poncy A, Antoniou A, Cordi S, Pierreux C, Jacquemin P, Lemaigre F. Transcription factors SOX4 and SOX9 cooperatively control development of bile ducts. Dev Biol. 2015;404:136-48 pubmed publisher
  62. Ohlmann C, Brecht I, Junker K, van der Zee J, Nistor A, Bohle R, et al. Sclerosing epithelioid fibrosarcoma of the kidney: clinicopathologic and molecular study of a rare neoplasm at a novel location. Ann Diagn Pathol. 2015;19:221-5 pubmed publisher
  63. Vanoli A, Argenti F, Vinci A, La Rosa S, Viglio A, Riboni R, et al. Hepatoid carcinoma of the pancreas with lymphoid stroma: first description of the clinical, morphological, immunohistochemical, and molecular characteristics of an unusual pancreatic carcinoma. Virchows Arch. 2015;467:237-45 pubmed publisher
  64. Bhagirath D, Zhao X, West W, Qiu F, Band H, Band V. Cell type of origin as well as genetic alterations contribute to breast cancer phenotypes. Oncotarget. 2015;6:9018-30 pubmed
  65. Miracco C, Toscano M, Butorano M, Baldino G, Tacchini D, Barone A, et al. Unusual clear cell, lymphoplasmacyte-rich, dural-based tumor with divergent differentiation: a tricky case mimicking a meningioma. Hum Pathol. 2015;46:1050-6 pubmed publisher
  66. Hines W, Yaswen P, Bissell M. Modelling breast cancer requires identification and correction of a critical cell lineage-dependent transduction bias. Nat Commun. 2015;6:6927 pubmed publisher
  67. Lee J, Garbe J, Vrba L, Miyano M, Futscher B, Stampfer M, et al. Age and the means of bypassing stasis influence the intrinsic subtype of immortalized human mammary epithelial cells. Front Cell Dev Biol. 2015;3:13 pubmed publisher
  68. Xiu Y, Jiang L, Liu W. Classic biphasic pulmonary blastoma with brain and axillary metastases: a case report with molecular analysis and review of literature. Int J Clin Exp Pathol. 2015;8:983-8 pubmed
  69. Li Q, Liu G, Yuan H, Wang J, Guo Y, Chen T, et al. Mucin1 shifts Smad3 signaling from the tumor-suppressive pSmad3C/p21(WAF1) pathway to the oncogenic pSmad3L/c-Myc pathway by activating JNK in human hepatocellular carcinoma cells. Oncotarget. 2015;6:4253-65 pubmed
  70. Elliott G, Hong C, Xing X, Zhou X, Li D, Coarfa C, et al. Intermediate DNA methylation is a conserved signature of genome regulation. Nat Commun. 2015;6:6363 pubmed publisher
  71. Simons M, Nagtegaal I, Overbeek L, Flucke U, Massuger L, Bulten J. A patient with a noninvasive mucinous ovarian borderline tumor presenting with late pleural metastases. Int J Gynecol Pathol. 2015;34:143-50 pubmed publisher
  72. Yui T, Ohmachi T, Matsuda K, Okamoto M, Taniyama H. Histochemical and immunohistochemical characterization of chordoma in ferrets. J Vet Med Sci. 2015;77:467-73 pubmed publisher
  73. Van de Laar E, Clifford M, Hasenoeder S, Kim B, Wang D, Lee S, et al. Cell surface marker profiling of human tracheal basal cells reveals distinct subpopulations, identifies MST1/MSP as a mitogenic signal, and identifies new biomarkers for lung squamous cell carcinomas. Respir Res. 2014;15:160 pubmed publisher
  74. Menck K, Scharf C, Bleckmann A, Dyck L, Rost U, Wenzel D, et al. Tumor-derived microvesicles mediate human breast cancer invasion through differentially glycosylated EMMPRIN. J Mol Cell Biol. 2015;7:143-53 pubmed publisher
  75. BaÅŸak K, KiroÄŸlu K. Multiple oncocytic cystadenoma with intraluminal crystalloids in parotid gland: case report. Medicine (Baltimore). 2014;93:e246 pubmed publisher
  76. Vogels R, Vlenterie M, Versleijen Jonkers Y, Ruijter E, Bekers E, Verdijk M, et al. Solitary fibrous tumor - clinicopathologic, immunohistochemical and molecular analysis of 28 cases. Diagn Pathol. 2014;9:224 pubmed publisher
  77. Lowdon R, Zhang B, Bilenky M, Mauro T, Li D, Gascard P, et al. Regulatory network decoded from epigenomes of surface ectoderm-derived cell types. Nat Commun. 2014;5:5442 pubmed publisher
  78. Raap M, Antonopoulos W, Dämmrich M, Christgen H, Steinmann D, Länger F, et al. High frequency of lobular breast cancer in distant metastases to the orbit. Cancer Med. 2015;4:104-11 pubmed publisher
  79. Tanida T, Tanemura M, Miyoshi E, Nagano H, Furukawa K, Nonaka Y, et al. Pancreatic cancer immunotherapy using a tumor lysate vaccine, engineered to express α-gal epitopes, targets pancreatic cancer stem cells. Int J Oncol. 2015;46:78-90 pubmed publisher
  80. Cai X, Dai Z, Reeves R, Caballero Benítez A, Duran K, Delrow J, et al. Autonomous stimulation of cancer cell plasticity by the human NKG2D lymphocyte receptor coexpressed with its ligands on cancer cells. PLoS ONE. 2014;9:e108942 pubmed publisher
  81. Libard S, Popova S, Amini R, Kärjä V, Pietiläinen T, Hämäläinen K, et al. Human cytomegalovirus tegument protein pp65 is detected in all intra- and extra-axial brain tumours independent of the tumour type or grade. PLoS ONE. 2014;9:e108861 pubmed publisher
  82. Gurzu S, Ciortea D, Tamasi A, Golea M, Bodi A, Sahlean D, et al. The immunohistochemical profile of granular cell (Abrikossoff) tumor suggests an endomesenchymal origin. Arch Dermatol Res. 2015;307:151-7 pubmed publisher
  83. Kasem K, Lam A. Adrenal oncocytic phaeochromocytoma with putative adverse histologic features: a unique case report and review of the literature. Endocr Pathol. 2014;25:416-21 pubmed publisher
  84. Li L, Fan X, Xia Q, Rao Q, Liu B, Yu B, et al. Concurrent loss of INI1, PBRM1, and BRM expression in epithelioid sarcoma: implications for the cocontributions of multiple SWI/SNF complex members to pathogenesis. Hum Pathol. 2014;45:2247-54 pubmed publisher
  85. Kurisaki Arakawa A, Suehara Y, Arakawa A, Takagi T, Takahashi M, Mitani K, et al. Deeply located low-grade fibromyxoid sarcoma with FUS-CREB3L2 gene fusion in a 5-year-old boy with review of literature. Diagn Pathol. 2014;9:163 pubmed publisher
  86. Sajin M, Luchian M, Hodorogea Prisăcaru A, Dumitru A, Pătraşcu O, Costache D, et al. Trichilemmal carcinoma - a rare cutaneous malignancy: report of two cases. Rom J Morphol Embryol. 2014;55:687-91 pubmed
  87. Jeon Y, Moon K, Park S, Chung D. Primary pulmonary myxoid sarcomas with EWSR1-CREB1 translocation might originate from primitive peribronchial mesenchymal cells undergoing (myo)fibroblastic differentiation. Virchows Arch. 2014;465:453-61 pubmed publisher
  88. Castorina A, Giunta S. Mucin 1 (MUC1) signalling contributes to increase the resistance to cell death in human bronchial epithelial cells exposed to nickel acetate. Biometals. 2014;27:1149-58 pubmed publisher
  89. Chuang H, Liao J, Chang H, Wang J, Lin S, Hsieh P. Ciliated muconodular papillary tumor of the lung: a newly defined peripheral pulmonary tumor with conspicuous mucin pool mimicking colloid adenocarcinoma: a case report and review of literature. Pathol Int. 2014;64:352-7 pubmed publisher
  90. Abdelzaher E, Abdallah D. Expression of mesothelioma-related markers in meningiomas: an immunohistochemical study. Biomed Res Int. 2014;2014:968794 pubmed publisher
  91. Severi G, FitzGerald L, Muller D, Pedersen J, Longano A, Southey M, et al. A three-protein biomarker panel assessed in diagnostic tissue predicts death from prostate cancer for men with localized disease. Cancer Med. 2014;3:1266-74 pubmed publisher
  92. Milione M, Gasparini P, Sozzi G, Mazzaferro V, Ferrari A, Casali P, et al. Ewing sarcoma of the small bowel: a study of seven cases, including one with the uncommonly reported EWSR1-FEV translocation. Histopathology. 2014;64:1014-26 pubmed publisher
  93. Miki Y, Hamada K, Yoshino T, Miyatani K, Takahashi K. Type AB thymoma is not a mixed tumor of type A and type B thymomas, but a distinct type of thymoma. Virchows Arch. 2014;464:725-34 pubmed publisher
  94. Lin Y, Kuo K, Wuputra K, Lin S, Ku C, Yang Y, et al. Bovine induced pluripotent stem cells are more resistant to apoptosis than testicular cells in response to mono-(2-ethylhexyl) phthalate. Int J Mol Sci. 2014;15:5011-31 pubmed publisher
  95. Sørdal Ø, Qvigstad G, Nordrum I, Sandvik A, Gustafsson B, Waldum H. The PAS positive material in gastric cancer cells of signet ring type is not mucin. Exp Mol Pathol. 2014;96:274-8 pubmed publisher
  96. Suzuki O, Abe M. Galectin-1-mediated cell adhesion, invasion and cell death in human anaplastic large cell lymphoma: regulatory roles of cell surface glycans. Int J Oncol. 2014;44:1433-42 pubmed publisher
  97. Toscano M, Butorano M, Cerase A, Miracco C. Correlative study of squash smear cytology with histopathology in a rare case of anaplastic giant cell ependymoma of the pineal. Histol Histopathol. 2014;29:1065-70 pubmed publisher
  98. Agoston A, Odze R. Evidence that gastric pit dysplasia-like atypia is a neoplastic precursor lesion. Hum Pathol. 2014;45:446-55 pubmed publisher
  99. Chen F, Becker A, LoTurco J. Contribution of tumor heterogeneity in a new animal model of CNS tumors. Mol Cancer Res. 2014;12:742-53 pubmed publisher
  100. Cyr A, Kulak M, Park J, Bogachek M, Spanheimer P, Woodfield G, et al. TFAP2C governs the luminal epithelial phenotype in mammary development and carcinogenesis. Oncogene. 2015;34:436-44 pubmed publisher
  101. Dadone B, Ambrosetti D, Carpentier X, Duranton Tanneur V, Burel Vandenbos F, Amiel J, et al. A renal metanephric adenoma showing both a 2p16e24 deletion and BRAF V600E mutation: a synergistic role for a tumor suppressor gene on chromosome 2p and BRAF activation?. Cancer Genet. 2013;206:347-52 pubmed
  102. Meng F, Takaori K, Ito T, Masui T, Kawaguchi M, Kawaguchi Y, et al. Expression of SOX9 in intraductal papillary mucinous neoplasms of the pancreas. Pancreas. 2014;43:7-14 pubmed publisher
  103. Yu L, Cheng H, Yang S. Clinicopathological and extensive immunohistochemical study of a type II pleuropulmonary blastoma. Fetal Pediatr Pathol. 2014;33:1-8 pubmed publisher
  104. Qiu S, Wei X, Huang W, Wu M, Qin Y, Li Y, et al. Diagnostic and therapeutic strategy and the most efficient prognostic factors of breast malignant fibrous histiocytoma. Sci Rep. 2013;3:2529 pubmed publisher
  105. Shintaku M, Yoneda H, Hirato J, Nagaishi M, Okabe H. Gliosarcoma with ependymal and PNET-like differentiation. Clin Neuropathol. 2013;32:508-14 pubmed publisher
  106. Zhao Y, Li W, Lang R, Yang Y, Gao X, Zheng Y, et al. Primary acinic cell carcinoma of the breast: a case report and review of the literature. Int J Surg Pathol. 2014;22:177-81 pubmed publisher
  107. Woessner D, Lim C. Disrupting BCR-ABL in combination with secondary leukemia-specific pathways in CML cells leads to enhanced apoptosis and decreased proliferation. Mol Pharm. 2013;10:270-7 pubmed publisher
  108. Carrasco M, Delgado I, Soria B, Martin F, Rojas A. GATA4 and GATA6 control mouse pancreas organogenesis. J Clin Invest. 2012;122:3504-15 pubmed publisher
  109. Kumar P, Kumar P, Lindberg L, Thirkill T, Ji J, Martsching L, et al. The MUC1 extracellular domain subunit is found in nuclear speckles and associates with spliceosomes. PLoS ONE. 2012;7:e42712 pubmed publisher
  110. O Mahony F, Faratian D, Varley J, Nanda J, Theodoulou M, Riddick A, et al. The use of automated quantitative analysis to evaluate epithelial-to-mesenchymal transition associated proteins in clear cell renal cell carcinoma. PLoS ONE. 2012;7:e31557 pubmed publisher
  111. Kopinke D, Murtaugh L. Exocrine-to-endocrine differentiation is detectable only prior to birth in the uninjured mouse pancreas. BMC Dev Biol. 2010;10:38 pubmed publisher